For instance, DPT can modulate the connection and adhesion of liver cancer and oral cancer cells to the ECM, thereby affecting the invasion and migration capacity (Fu et al. 2014; Yamatoji et al. 2012); It can also regulate the MEK-ERK-MYC signaling pathway, inhibiting the expression of downstream proteins such as CDK4, CDK6, and p21, which, in turn, suppresses the proliferation of thyroid cancer cells. Here, MYC is linked to lip and oral cavity carcinoma.